https://pubmed.ncbi.nlm.nih.gov/31816435/
Meta-Analysis
Pharmacol Res
. 2020 Jan;151:104588. doi: 10.1016/j.phrs.2019.104588. Epub 2019 Dec 6.
The influence of metformin on IGF-1 levels in humans: A systematic review and meta-analysis
Xiaodong Yang 1,
Hamed Kord-Varkaneh 2,
Sam Talaei 3,
Cain C T Clark 4,
Fernando Zanghelini 5,
Shing Cheng Tan 6,
Meysam Zarezadeh 7,
Seyed Mohammad Mousavi 8,
Jamal Rahmani 8,
Yong Zhang 9
Affiliations expand
Abstract
Background: A meta-analysis is needed to comprehensively consolidate findings from the influence of metformin on IGF-1 levels. The present study was conducted with the objective to accurately evaluate the influence of metformin intake on IGF-1 levels via a meta-analysis of randomized controlled trials.
Methods: A comprehensive systematic search was carried out in PubMed/MEDLINE, Web of Science, SCOPUS and Embase from inception until June 2019. Weighted mean difference (WMD) with the 95 % CI were applied for estimating the effects of metformin on serum IGF-1 levels.
Results: 11 studies involving a total of
569 individuals reported changes in IGF-1 plasma concentrations as an outcome measure. Pooled results demonstrated an overall non-significant decline in IGF-1 following metformin intake (WMD: -8.292 ng/ml, 95 % CI: -20.248, 3.664, p = 0.174) with heterogeneity among (p = 0.000,I2 = 87.1 %). The subgroup analyses displayed that intervention duration <12 weeks on children (WMD:-55.402 ng/ml, 95 % CI: -79.845, -30.960, I2 = 0.0 %) significantly reduced IGF-1.
Moreover, in age 18 < years older metformin intake (WMD: 15.125 ng/ml, 95 % CI: 5.522, 24.729, I2 = 92.5 %) significantly increased IGF-1 than 18 ≤ years older (WMD:-1.038 ng/ml, 95 % CI: -3.578,1.502,I2 = 78.0 %). Following dose-response evaluation, metformin intake reduced IGF-1 (coefficient for dose-response analysis= -13.14, P = 0.041 and coefficient for liner analysis= -0.066, P = 0.038) significantly based on treatment duration.
Conclusion: We found in children, intervention duration <12 weeks yielded significant reductions in IGF-1, whilst paradoxically, in participants >18 years old, metformin intake significantly increased IGF-1. We suggest that caution be taken when interpreting the findings of this review, particularly given the discordant supplementation practices between children and adults.
SO LOWERING OF ABOUT 8.00 NG/ML WORST CASE SCENARIO.
Meta-Analysis
Ageing Res Rev
. 2020 Jan;57:100996. doi: 10.1016/j.arr.2019.100996. Epub 2019 Dec 6.
The influence of vitamin D supplementation on IGF-1 levels in humans: A systematic review and meta-analysis
Hamed Kord-Varkaneh 1,
Giulia Rinaldi 2,
Azita Hekmatdoost 3,
Somaye Fatahi 4,
Shing Cheng Tan 5,
Mahdi Shadnoush 1,
Vahid Khani 6,
Seyed Mohammad Mousavi 7,
Meysam Zarezadeh 8,
Shekoufeh Salamat 9,
Hiba Bawadi 10,
Jamal Rahmani 11
Affiliations expand
Abstract
Background: Inconsistencies exist with regard to influence of vitamin D supplementation on IGF-1 levels. The inconsistencies could be attributed to several factors, such as dosage and duration of intervention, among others. To address these inconsistencies, this study was conducted to determine the impact of vitamin D supplementation on IGF-1 levels through a systematic review and meta-analysis of randomized controlled trials (RCTs).
Methods: A comprehensive systematic search was carried out in PubMed/MEDLINE, Web of Science, SCOPUS and Embase for RCTs that investigated the impact of vitamin D intake on circulating IGF-1 levels from inception until June 2019. Weighted mean difference (WMD) with the 95 % CI were applied for estimating combined effect size. Subgroup analysis was performed to specify the source of heterogeneity among studies.
Results: Pooled results from eight studies demonstrated an overall non-significant increase in IGF-1 following vitamin D supplementation (WMD: 4 ng/ml, 95 % CI: -4 to 11). However, a significant degree of heterogeneity among studies was observed (I2 = 66 %).
The subgroup analyses showed that vitamin D dosage of ≤1000 IU/day (WMD: 10 ng/ml) significantly increased IGF-1 compared to the vitamin D dosage of <1000 IU/day (WMD: -1 ng/ml). Moreover, intervention duration ≤12 weeks (WMD: 11 ng/ml) significantly increased IGF-1 compared to intervention duration <12 weeks (WMD: -3 ng/ml). In the epidemiological cohort study, participants under 60 years of age with a higher dietary vitamin D intake had significantly higher IGF-1 levels when compared to those with lower dietary vitamin D intake in second categories.
Conclusion: The main results indicate a non-significant increase in IGF-1 following vitamin D supplementation. Additionally, vitamin D dosages of <1000 IU/day and intervention durations of <12 weeks significantly raised IGF-1 levels.
So taking GREATER than 1000iu of D a day increase IGF by 10ng/ml.
Stack that with basic training which we all do: